The FDA Tightens the Rules for Covid-19 Antibody Blood Tests
In a reversal, agency officials raised the bar for validation and accuracy standards, citing concerns about flawed tests and fraudulent marketing.
In a reversal, agency officials raised the bar for validation and accuracy standards, citing concerns about flawed tests and fraudulent marketing.